Silence Therapeutics plc cotiza a 8.87 USD y tiene una capitalización bursátil de $551M. En los últimos 12 meses ha facturado $615000 con un margen de flujo de caja libre del -11149.5%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is i…
| Métrica | SLN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 61.5% | 57.0% | +4.5% |
| Operating Margin | -16292.8% | -38.6% | -16254.2% |
| Net Margin | -15851.9% | -33.6% | -15818.3% |
| FCF Margin | -11149.5% | -13.9% | -11135.7% |
| ROE | -142.2% | -40.4% | -101.8% |
| ROA | -67.4% | -32.0% | -35.4% |
| Current Ratio | 8.72 | 2.84 | +5.88 |
| Debt / Equity | — | 0.28 | — |